ResearcherOregon Health & Science UniversityActive in the last 2 years

Lei G. Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0664-2704; OpenAlex author ID A5100435842. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer. Co-author DOI 10.3390/cancers16213650 ↗
Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems. Co-author DOI 10.1371/journal.pone.0229407 ↗
Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. Co-author DOI 10.1016/j.ymeth.2019.06.008 ↗
Far-Red and Near-Infrared Seminaphthofluorophores for Targeted Pancreatic Cancer Imaging. Co-author DOI 10.1021/acsomega.6b00403 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Summer L. Gibbs · 4 shared papers, 2017–2024 · strength 0.49
Robert M. Strongin · 2 shared papers, 2017–2019 · strength 0.18
- Paper Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. DOI 10.1016/j.ymeth.2019.06.008 ↗
- Paper Far-Red and Near-Infrared Seminaphthofluorophores for Targeted Pancreatic Cancer Imaging. DOI 10.1021/acsomega.6b00403 ↗
Gordon Brent Mills · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Brett C. Sheppard · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Skye C. Mayo · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Adel Kardosh · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Ranish K. Patel · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Melissa H. Wong · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Charles D. Lopez · 1 shared paper, 2024 · strength 0.17
- Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650 ↗
Allison Solanki · 1 shared paper, 2020 · strength 0.15
- Paper Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer mo… DOI 10.1371/journal.pone.0229407 ↗
Ian Munhenzva · 1 shared paper, 2019 · strength 0.11
- Paper Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. DOI 10.1016/j.ymeth.2019.06.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.